![Uttam Yashwant Patil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Uttam Yashwant Patil
Vorstandsvorsitzender bei
ABVC BIOPHARMA, INC.
Vermögen: 62 143 $ am 31.08.2026
Profil
Dr. Uttam Yashwant Patil is a Co-Chief Executive Officer at AiBtl BioPharma, Inc., a Chief Executive & Financial Officer at ABVC BioPharma, Inc., a Chief Operating & Scientific Officer at Biokey, Inc. and a Manager-Research & Development at Rgene Corp.
He received his undergraduate degree from the University of Pune, a graduate degree from the University of Pune and a doctorate degree from National Tsing-Hua University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABVC BIOPHARMA, INC. 0.27% | 27.02.2026 | 72’428 ( 0.27% ) | 62 143 $ | 31.08.2026 |
Aktive Positionen von Uttam Yashwant Patil
| Unternehmen | Position | Beginn |
|---|---|---|
| ABVC BIOPHARMA, INC. | Vorstandsvorsitzender | 21.06.2023 |
Biokey, Inc.
 Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Geschäftsführer | 01.05.2023 |
Rgene Corp.
 Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2023 |
Ausbildung von Uttam Yashwant Patil
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
National Tsing-Hua University
 National Tsing-Hua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
 University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABVC BioPharma, Inc.
 ABVC BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops drugs and medical devices in the fields of oncology, ophthalmology and central nervous system | Health Technology |
Biokey, Inc.
Biokey, Inc. Pharmaceuticals: GenericHealth Technology Develops and markets generic drugs | Health Technology |
Rgene Corp.
Rgene Corp. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
